Key result
Pulsed field ablation appears cost-effective compared with thermal ablation for atrial fibrillation at 1 year.
Why the study?
Pulsed field ablation offers comparable clinical effectiveness and improved procedural efficiency for AF compared with thermal ablation, but may involve higher equipment costs. Cost-effectiveness analyses are needed to inform its adoption within healthcare systems with limited resources.
Is pulsed field ablation cost-effective compared to conventional thermal ablation in patients with atrial fibrillation?
Is pulsed field ablation cost-effective compared to conventional thermal ablation in patients with atrial fibrillation?
Preliminary evidence suggests pulsed field ablation for atrial fibrillation is likely cost-effective due to shorter procedural times offsetting higher equipment costs, though longer-term cost-effectiveness analyses are needed.
Answers are grounded in this paper and cite their sources.
PFA may offer safer, more efficient AF ablation; leaves open cost-effectiveness for routine adoption pending dedicated analyses.
PURPOSE OF REVIEW: Catheter ablation is increasingly used as a primary or first-line rhythm-control strategy in the treatment of atrial fibrillation (AF). Pulsed field ablation (PFA) is an emerging catheter ablation modality that offers comparable clinical effectiveness as thermal ablation whilst avoiding safety events related to thermal injury and improving procedural efficiency. PFA may be associated with increased equipment costs. Cost-effectiveness analyses (CEA) help inform adoption of newer technologies such as PFA within healthcare systems with limited resources. RECENT FINDINGS: Accordingly, our review provides a primer for CEA and examines the evidence for PFA. Recent studies have demonstrated that PFA is at least as effective as conventional thermal ablation (radiofrequency or cryoballoon) in treating AF and may be an effective first-line rhythm control therapy. PFA is associated with shorter procedural times which increases throughput and may help to offset higher equipment costs. SUMMARY: Preliminary work suggests that PFA is likely cost-effective but findings must be interpreted with caution as there are a limited number of CEA and follow-up was generally limited to 1 year post ablation. Additional CEA across healthcare jurisdictions with longer time horizons are required to confirm these findings and may inform uptake of PFA.
No takes yet. Share an insight, caveat, or question.
Qeska et al. (2026) conducted a review in Atrial fibrillation. Pulsed field ablation vs. Conventional thermal ablation (radiofrequency or cryoballoon) was evaluated on Cost-effectiveness and clinical effectiveness. Pulsed field ablation is likely cost-effective compared with thermal ablation for atrial fibrillation, though current analyses are limited to 1-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: